14 Dec 2007 WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX(R)
13 Dec 2007 Merck Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis
13 Dec 2007 Genmab announces details of planned Ofatumumab Phase II study in multiple sclerosis
13 Dec 2007 Genmab initiates Ofatumumab Phase II study in diffuse large b-cell lymphoma
11 Dec 2007 ThromboGenics Presents Results of the Phase I Trial of TB-402 at thePrestigious American Society of Hematology Annual Meeting
11 Dec 2007 Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
11 Dec 2007 Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH
11 Dec 2007 GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
10 Dec 2007 Genitope Corporation Presents New Data On Its Therapeutic Monoclonal Antibodies To Potentially Treat B-Cell Malignancies
10 Dec 2007 MorphoSys Broadens Scope of Collaboration with GeneFrontier
10 Dec 2007 PDL BioPharma Presents Data on Novel Monoclonal Antibody for Multiple Myeloma at the 2007 American Society of Hematology Annual Meeting
10 Dec 2007 Ablynx announces extension of Nanobody (R) drug discovery and development alliance
10 Dec 2007 Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
10 Dec 2007 Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma
10 Dec 2007 Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
10 Dec 2007 Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10 Dec 2007 Biolex Researchers Present Results of Anti-CD20 Antibody With Optimized Glycosylation at ASH Conference
09 Dec 2007 ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting for TAP Compound AVE9633
08 Dec 2007 ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting with Targeted Anticancer Compounds IMGN901 (HuN901-DM1) and AVE1642
07 Dec 2007 Genmab's HuMax-CD38 Enters Phase I/II Clinical Trial For Multiple Myeloma
07 Dec 2007 Seattle Genetics Initiates SGN-40 Phase IIb Clinical Trial in Combination with Rituxan and Chemotherapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
06 Dec 2007 Raven biotechnologies, Inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
05 Dec 2007 Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
05 Dec 2007 BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer
05 Dec 2007 Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up